A new development in the world of vaccines may revolutionize the way we protect ourselves from both Covid-19 and the flu. Moderna, a leading vaccine maker, has revealed positive results from its late-stage trial of a combined Covid/flu vaccine called mRNA-1083. The trial showed that those who received mRNA-1083 had a stronger immune response compared to those who received separate flu and Covid vaccines. This is a significant breakthrough, especially for older adults who typically have less robust responses to vaccines. The study also found that the combined vaccine was well-tolerated, with minor side effects similar to those of individual vaccines.
Public health experts believe that such a combined vaccine could help protect millions of people who get sick from the flu and Covid each year. With vaccine hesitancy on the rise and people experiencing fatigue from the pandemic, a convenient and effective combined vaccine could be a game-changer in the fight against both viruses. The results of Moderna’s trial have not been peer-reviewed yet, but the company plans to present the data at a medical conference and submit it for publication. If deemed safe and effective by the FDA, a combined Covid/flu vaccine could provide a much-needed solution to the ongoing public health crisis.
